What Researchers Did
This systematic review examined transient osteoporosis of the hip (TOH), its clinical features, and discussed the off-label use of hyperbaric oxygen therapy (HBOT) as an alternative treatment when other conservative methods fail.
What They Found
The review explored the clinical presentation, pathophysiology, and diagnosis of transient osteoporosis of the hip (TOH). It discussed hyperbaric oxygen therapy (HBOT) as an alternative, off-label treatment option for patients with TOH who have not responded to other conservative treatments like medication or weight-bearing restrictions.
Canadian Relevance
No direct Canadian connection identified. This study does not cover a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
A limitation is that this systematic review discusses the off-label use of HBOT for TOH without presenting new primary research data or specific efficacy outcomes from controlled trials.